Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00646763 · ClinicalTrials.gov registry record · Phase 2
A Randomized Study of the Site for Growth Factor Injection for Patients Undergoing Autologous Stem Cell Transplantation
A Phase 2 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00646763 is a Phase 2 study that was terminated before completion, run by Emory University. The registered enrollment target is 35 participants.
The verdict
NCT00646763, a Phase 2 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether or not the injection site of cytokines, or growth factors, has an effect on peripheral blood stem cell collection.
Interventions
- DRUG G-CSF, GM-CSF administered at extremities
- DRUG G-CSF and GMCSF administered at abdomen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00646763
The ClinicalTrials.gov registry entry for NCT00646763 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which G-CSF, GM-CSF administered at extremities is the first listed.
NCT00646763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00646763 about?
NCT00646763 is a clinical study titled "A Randomized Study of the Site for Growth Factor Injection for Patients Undergoing Autologous Stem Cell Transplantation". The purpose of this study is to determine whether or not the injection site of cytokines, or growth factors, has an effect on peripheral blood stem cell collection.
What is the current status of trial NCT00646763?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2008-04. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00646763?
The interventions under investigation include: G-CSF, GM-CSF administered at extremities (DRUG), G-CSF and GMCSF administered at abdomen (DRUG).
Who is sponsoring clinical trial NCT00646763?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.